| Catalog Number |
03P76-25 |
| Medical Device Problem Code |
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
| Health Effect - Clinical Codes |
Sepsis (2067); Septic Shock (2068); Elevated ketones/Diabetic Ketoacidosis (2364); Respiratory Acidosis (2482); Cholangitis (4821)
|
| Date of Event |
12/17/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
On 20-dec-2022, abbott point of care was contacted by a customer regarding i-stat eg7+ cartridges that yielded a suspected discrepant hemoglobin results on a patient with diabetic ketoacidosis and cholangitis.There was no additional patient information available at the time of this report.Patient's clinical symptoms were septic shock, acidosis, unconscious, unstable vital sign.Customer states that the patient died that night.(b)(6).At this time there is no reason to suspect a malfunction exists.The patient died as a result of complications related to septic shock, acidosis, unconscious, unstable vital sign as presented.There is no reason to suspect that the i-stat caused or contributed to the patient's demise.The reporting decision was based on information available that suggests the product was not performing within the variability of the assay.The investigation is underway.
|
| |
|
Additional Manufacturer Narrative
|
|
Apoc incident # (b)(4).Apoc labeling will be evaluated during the investigation as pertaining to the event.
|
| |
|
Additional Manufacturer Narrative
|
|
Apoc incident: # (b)(4).The investigation was completed on 01-feb-2023.A review of the device history record (dhr) confirmed the cartridge lot met finished goods release criteria.Retained cartridge testing met the acceptance criteria found in q04.01.003 rev.Ak, appendix 1 - product complaint level 2 and level 3 investigation procedure.No deficiency has been determined for eg7+ cartridge lot n22194.
|
| |
|
Event or Problem Description
|
|
Na.
|
| |
|
Search Alerts/Recalls
|